HK1063784A1 - Non-nucleoside reverse transcriptase inhibitors - Google Patents

Non-nucleoside reverse transcriptase inhibitors

Info

Publication number
HK1063784A1
HK1063784A1 HK04106555A HK04106555A HK1063784A1 HK 1063784 A1 HK1063784 A1 HK 1063784A1 HK 04106555 A HK04106555 A HK 04106555A HK 04106555 A HK04106555 A HK 04106555A HK 1063784 A1 HK1063784 A1 HK 1063784A1
Authority
HK
Hong Kong
Prior art keywords
reverse transcriptase
transcriptase inhibitors
nucleoside reverse
nucleoside
inhibitors
Prior art date
Application number
HK04106555A
Other languages
English (en)
Inventor
Stefan Lindstrom
Christer Sahlberg
Hans Wallberg
Ganaidy Kalyanov
Lourdes Oden
Lotta Naeslund
Original Assignee
Medivir Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Medivir Ab filed Critical Medivir Ab
Publication of HK1063784A1 publication Critical patent/HK1063784A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4433—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a six-membered ring with oxygen as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4436—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a heterocyclic ring having sulfur as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C245/00—Compounds containing chains of at least two nitrogen atoms with at least one nitrogen-to-nitrogen multiple bond
    • C07C245/12—Diazo compounds, i.e. compounds having the free valencies of >N2 groups attached to the same carbon atom
    • C07C245/14—Diazo compounds, i.e. compounds having the free valencies of >N2 groups attached to the same carbon atom having diazo groups bound to acyclic carbon atoms of a carbon skeleton
    • C07C245/18—Diazo compounds, i.e. compounds having the free valencies of >N2 groups attached to the same carbon atom having diazo groups bound to acyclic carbon atoms of a carbon skeleton the carbon skeleton being further substituted by carboxyl groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C43/00—Ethers; Compounds having groups, groups or groups
    • C07C43/02—Ethers
    • C07C43/20—Ethers having an ether-oxygen atom bound to a carbon atom of a six-membered aromatic ring
    • C07C43/23—Ethers having an ether-oxygen atom bound to a carbon atom of a six-membered aromatic ring containing hydroxy or O-metal groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/93—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems condensed with a ring other than six-membered
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Virology (AREA)
  • Engineering & Computer Science (AREA)
  • AIDS & HIV (AREA)
  • Molecular Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Furan Compounds (AREA)
  • Pyrane Compounds (AREA)
HK04106555A 2001-03-05 2004-08-31 Non-nucleoside reverse transcriptase inhibitors HK1063784A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE0100733A SE0100733D0 (sv) 2001-03-05 2001-03-05 Non-nucleoside reverse transcriptase inhibitors
PCT/EP2002/002328 WO2002070516A2 (en) 2001-03-05 2002-03-04 Cyclopropaheterocycles as non-nucleoside reverse transcriptase inhibitors

Publications (1)

Publication Number Publication Date
HK1063784A1 true HK1063784A1 (en) 2005-01-14

Family

ID=20283208

Family Applications (2)

Application Number Title Priority Date Filing Date
HK04106555A HK1063784A1 (en) 2001-03-05 2004-08-31 Non-nucleoside reverse transcriptase inhibitors
HK08105844.9A HK1111155A1 (en) 2001-03-05 2008-05-26 Non-nucleoside reverse transcriptase inhibitors

Family Applications After (1)

Application Number Title Priority Date Filing Date
HK08105844.9A HK1111155A1 (en) 2001-03-05 2008-05-26 Non-nucleoside reverse transcriptase inhibitors

Country Status (22)

Country Link
US (3) US6716850B2 (xx)
EP (1) EP1373261B1 (xx)
JP (2) JP4463478B2 (xx)
KR (1) KR100884494B1 (xx)
CN (2) CN1264839C (xx)
AR (1) AR035941A1 (xx)
AT (1) ATE508128T1 (xx)
AU (1) AU2002308231B2 (xx)
BR (1) BR0207886A (xx)
CA (1) CA2438524C (xx)
DE (1) DE60239924D1 (xx)
DK (1) DK1373261T3 (xx)
ES (1) ES2364926T3 (xx)
HK (2) HK1063784A1 (xx)
IL (2) IL157543A0 (xx)
MX (1) MXPA03008040A (xx)
MY (1) MY137083A (xx)
PL (1) PL207392B1 (xx)
RU (1) RU2281284C2 (xx)
SE (1) SE0100733D0 (xx)
TW (1) TWI228990B (xx)
WO (1) WO2002070516A2 (xx)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004021969A2 (en) * 2002-09-05 2004-03-18 Medivir Ab Non-nucleoside reverse transcriptase inhibitors
EP1680431A1 (en) * 2003-10-17 2006-07-19 Rigel Pharmaceuticals, Inc. Benzothiazole and thiazole'5,5-b!pyridine compositions and their use as ubiquitin ligase inhibitors
SE0400021D0 (sv) * 2004-01-08 2004-01-08 Medivir Ab Non-nucleoside reverse transcriptase inhibitors
DE602004024584D1 (de) * 2004-01-08 2010-01-21 Medivir Ab Inhibitoren der nicht-nukleotidischen reversen transkriptase
GB0608876D0 (en) * 2006-05-05 2006-06-14 Medivir Ab Combination therapy
PE20080069A1 (es) 2006-05-15 2008-02-22 Merck & Co Inc Compuestos biciclicos como agonistas del receptor 40 acoplado a proteina g (gpr40)
EP3013798B1 (en) * 2013-06-28 2018-06-27 BeiGene, Ltd. Fused tricyclic urea compounds as raf kinase and/or raf kinase dimer inhibitors
EP3013797B1 (en) 2013-06-28 2018-01-03 BeiGene, Ltd. Fused tricyclic amide compounds as multiple kinase inhibitors
WO2015089842A1 (en) * 2013-12-20 2015-06-25 Merck Sharp & Dohme Corp. Novel tricyclic calcium sensing receptor antagonists for the treatment of osteoporosis

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA973885A (en) * 1969-08-22 1975-09-02 Universal Oil Products Company Vinylation of aromatic compounds
US3803175A (en) 1969-08-22 1974-04-09 Universal Oil Prod Co Preparation of coumarin compounds
US4931221A (en) * 1988-12-30 1990-06-05 Ppg Industries, Inc. Photochromic spiropyran compounds
IL102548A (en) 1991-08-02 1998-08-16 Medivir Ab Use of painting derivatives in the preparation of drugs for VIH inhibition and treatment of SDIA and new compounds
NZ273741A (en) 1993-08-24 2000-06-23 Medivir Ab Heterocyclically-substituted guanidine, urea and thiourea derivatives
HU228886B1 (en) * 1998-01-16 2013-06-28 Medivir Ab Antiviral compounds, process for producing them and pharmaceutical compositions containing them
US5998411A (en) 1998-03-17 1999-12-07 Hughes Institute Heterocyclic nonnucleoside inhibitors of reverse transcriptase
WO1999051613A1 (en) 1998-04-03 1999-10-14 Medivir Ab Prodrugs of phosphorous-containing pharmaceuticals
US6136335A (en) 1998-12-31 2000-10-24 Hughes Institute Phenethyl-5-bromopyridylthiourea (PBT) and dihydroalkoxybenzyloxopyrimidine (DABO) derivatives exhibiting spermicidal activity
US7186736B1 (en) 1999-03-20 2007-03-06 Parker Hughes Institute NNI for treatment of multi-drug resistant HIV
US6469034B1 (en) 1999-06-23 2002-10-22 Parker Hughes Institute Cyclohexenyl-ethyl-thiourea compounds for inhibiting HIV reverse transcriptase
US6207688B1 (en) 1999-06-23 2001-03-27 Parker Hughes Institute Phenethyl-thiourea compounds and use
US6124324A (en) 1999-06-23 2000-09-26 Hughes Institute Thiophene-ethyl thiourea compounds and use

Also Published As

Publication number Publication date
ES2364926T3 (es) 2011-09-16
AU2002308231B2 (en) 2007-05-10
MY137083A (en) 2008-12-31
CN101081843B (zh) 2010-10-13
CA2438524A1 (en) 2002-09-12
JP2009102436A (ja) 2009-05-14
DE60239924D1 (de) 2011-06-16
RU2281284C2 (ru) 2006-08-10
KR100884494B1 (ko) 2009-02-18
EP1373261A2 (en) 2004-01-02
ATE508128T1 (de) 2011-05-15
US7405310B2 (en) 2008-07-29
DK1373261T3 (da) 2011-08-29
MXPA03008040A (es) 2004-05-24
PL207392B1 (pl) 2010-12-31
RU2003129513A (ru) 2005-03-20
JP2004529112A (ja) 2004-09-24
IL157543A0 (en) 2004-03-28
WO2002070516A3 (en) 2003-02-06
CN1494545A (zh) 2004-05-05
US6894177B2 (en) 2005-05-17
PL364414A1 (en) 2004-12-13
US20030069224A1 (en) 2003-04-10
US20050240035A1 (en) 2005-10-27
CN1264839C (zh) 2006-07-19
AR035941A1 (es) 2004-07-28
TWI228990B (en) 2005-03-11
US6716850B2 (en) 2004-04-06
JP4463478B2 (ja) 2010-05-19
SE0100733D0 (sv) 2001-03-05
EP1373261B1 (en) 2011-05-04
BR0207886A (pt) 2004-08-17
KR20030086601A (ko) 2003-11-10
CN101081843A (zh) 2007-12-05
HK1111155A1 (en) 2008-08-01
IL157543A (en) 2010-11-30
WO2002070516A2 (en) 2002-09-12
US20030187266A1 (en) 2003-10-02
CA2438524C (en) 2011-11-29

Similar Documents

Publication Publication Date Title
HK1080849A1 (en) Non-nucleoside reverse transcriptase inhibitors
PL378556A1 (pl) Nienukleozydowe inhibitory odwrotnej transkryptazy
HK1111155A1 (en) Non-nucleoside reverse transcriptase inhibitors
ZA200306549B (en) Benzophenones as inhibitors of reverse transcriptase.
IL144349A0 (en) Non-nucleoside reverse transcriptase inhibitors
PL395096A1 (pl) Inhibitory kinaz tyrozynowych
EP1496910A4 (en) KINASE INHIBITORS
TWI372619B (en) Non-nucleoside reverse transcriptase inhibitors
AU2002367773A8 (en) Fab i inhibitors
AU2003269628A1 (en) Non-nucleoside reverse transcriptase inhibitors
SI1569907T1 (sl) Na nikotinamidu osnovani kinazni inhibitorji
EP1558609A4 (en) KINASE INHIBITORS
IL152819A0 (en) Non-nucleoside reverse transcriptase inhibitors
EP1569907A4 (en) NICOTINAMIDE-BASED KINASE HEMMER
EP1047656A4 (en) NON-NUCLEOSIDIC REVERSE TRANSCRIPTASE INHIBITORS WITH A COMMON ALCENYLDIARYLMETHANE STRUCTURE
EP1326640A4 (en) NON-NUCLEOSIDIC REVERSE-TRANSCRIPTASE INHIBITOR AS ANTIRETROVIRAL THERAPY
HU0303925D0 (en) Expansion dowel
HRP20040886A2 (en) Non-nucleoside reverse transcriptase inhibitors
SI1294720T1 (sl) Nenukleozidni inhibitorji reverzne transkriptaze
AU2002355614A1 (en) Non-nucleoside reverse transcriptase inhibitors
DK1373267T3 (da) Non-nucleoside revers transkriptase-inhibitorer
GB0128453D0 (en) Inhibitors
GB0101135D0 (en) Inhibitors
GB0101134D0 (en) Inhibitors

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20140304